CarthroniX
About:
CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin regeneration, and novel solutions.
Website: https://www.carthronix.com
Top Investors: Pacira Pharmaceuticals
Description:
CarthroniX develops small-molecule-based therapies for cartilage diseases, including arthritis. They are able to preserve, repair, and regenerate cartilage in joints and simultaneously suppress inflammation.
Total Funding Amount:
$2.25M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Lancaster, California, United States
Founded Date:
2015-01-01
Contact Email:
info(AT)carthronix.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-04-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai